CNS	Central nervous system;
NAMs	Negative allosteric modulators;
PAMs	Positive allosteric modulators;
GAMSAs	GABAA-Receptor-Modulating Steroid Antagonists;
THDOC	Tetrahydrodeoxicorticosterone;
DHEAS	Dehydroepiandrosterone sulphate;
PD	Parkinson’s disease;
HE	Hepatic encephalopathy;
MHE	Minimal hepatic encephalopathy;
PBC	Primary biliary cholangitis;
MoCA	Montreal Cognitive Assessment;
PHES	Psychometric Hepatic Encephalopathy Score;
EEG	Electroencephalogram;
UDCA	Ursodeoxycholic acid;
BDL	Bile duct ligation;
FDA	Food and Drug Administration;
ODD	Orphan drug designation;
TH	Tyrosine hydroxylase;
6-OHDA	6-Hydroxydopamine.